The Penn State Milton S. Hershey Medical Center and Penn State College of Medicine are opening an institute dedicated to personalized medicine in which clinicians tailor individualized therapies according to patients’ genomic makeups, particularly for oncology patients, to produce better outcomes.
The institute, scheduled to open in June, will collaborate with other departments and institutes at the Hershey campus, including the Penn State Clinical and Translational Science Institute, to advance research in this field and to translate that research into clinical applications.
Read the fully story: http://hcp.lv/ziyIGe
Source: MEDCITY News
Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent
December 5th 2023Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.
Read More
Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream
December 5th 2023Two posters presented at the 2023 Fall Clinical Dermatology Conference examined patient demographics, clinical characteristics, and outcomes in patients with plaque psoriasis treated with tapinerof cream.
Read More